A recent study published in The Lancet Diabetes & Endocrinology highlights significant gaps in diabetes diagnosis and management globally. Conducted by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, the analysis examined the diabetes care cascade from 2000 to 2023 across 204 countries and territories.
The findings reveal that in 2023, approximately 44% of individuals aged 15 and older with diabetes remain undiagnosed, with young adults exhibiting the highest levels of underdiagnosis. Among those diagnosed, 91% are receiving some form of pharmacological treatment; however, only 42% achieve optimal blood sugar management. This results in just 21% of the global diabetic population being effectively managed.
The research identifies notable disparities in diagnosis and treatment across different regions. High-income North America reported the highest diagnosis rates, while high-income Asia Pacific had the most effective treatment among diagnosed individuals. Southern Latin America excelled in optimal blood sugar management. Conversely, Central sub-Saharan Africa showed alarming underdiagnosis, with fewer than 20% of individuals aware of their condition.
Projected estimates suggest that by 2050, 1.3 billion people will be living with diabetes, raising concerns about the potential for a silent epidemic if a significant portion remains undiagnosed. The study emphasizes the critical need for investment in screening programs, particularly for younger populations and in underserved regions, to improve access to necessary medications and monitoring tools.
In response to these challenges, the World Health Organization has set a goal to ensure that 80% of individuals with diabetes are clinically diagnosed by 2030. The research was funded by the Bill & Melinda Gates Foundation, underscoring the importance of continued support for diabetes management initiatives.